ARGENX SE

ARGX
Real-time Quote. Real-time  - 10/18 09:59:41 am
252.3EUR -1.18%

Turn to zoom
Prev.255.3000
Open254.5000
High255.2000
Low249.7000
Volume22 650
Latest news
10/08
10/08
10/08
10/07
Chart ARGENX SE
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishNeutral
Resistance272297310
Spread/Res.-7,8%-16%-19%
Spread/Supp.-0,12%-0,12%14%
Support251251219
Financials
Sales 2021 442 M 513 M 513 M
Net income 2021 -346 M -402 M -402 M
Net cash 2021 1 058 M 1 228 M 1 228 M
P/E ratio 2021 -37,8x
Yield 2021 -
Capitalization 13 152 M 15 257 M 15 263 M
EV / Sales 2021 27,4x
EV / Sales 2022 60,2x
Nbr of Employees 336
Free-Float 99,1%
Company
argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2021-10-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 255,30 €
Average target price 323,12 €
Spread / Average Target 26,6%